Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme 2 selected

Guidance programme

Showing 621 to 630 of 911

TitleReference numberPublishedLast updated
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumoursTA488
Aflibercept for treating choroidal neovascularisationTA486
Sarilumab for moderate to severe rheumatoid arthritisTA485
Immunosuppressive therapy for kidney transplant in adultsTA481
Immunosuppressive therapy for kidney transplant in children and young peopleTA482
Tofacitinib for moderate to severe rheumatoid arthritisTA480
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the kneeTA477
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphomaTA478
Reslizumab for treating severe eosinophilic asthmaTA479
Cetuximab and panitumumab for previously untreated metastatic colorectal cancerTA439

Results per page

  1. 10
  2. 25
  3. 50
  4. All